000 01715 a2200481 4500
005 20250513192146.0
264 0 _c20001019
008 200010s 0 0 eng d
022 _a0896-8411
024 7 _a10.1006/jaut.1999.0319
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMatteson, D M
245 0 0 _aInhibition of experimental melanin protein-induced uveitis (EMIU) by targeting nitric oxide via phosphatidylcholine-specific phospholipase C.
_h[electronic resource]
260 _bJournal of autoimmunity
_cSep 1999
300 _a197-204 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aAutoimmune Diseases
_xchemically induced
650 0 4 _aBridged-Ring Compounds
_xtherapeutic use
650 0 4 _aDown-Regulation
650 0 4 _aEnzyme Induction
_xdrug effects
650 0 4 _aEye Proteins
_ximmunology
650 0 4 _aFas Ligand Protein
650 0 4 _aFemale
650 0 4 _aMelanins
_ximmunology
650 0 4 _aMembrane Glycoproteins
_xisolation & purification
650 0 4 _aNitric Oxide
_xmetabolism
650 0 4 _aNitric Oxide Synthase
_xbiosynthesis
650 0 4 _aNitric Oxide Synthase Type II
650 0 4 _aNorbornanes
650 0 4 _aRats
650 0 4 _aRats, Inbred Lew
650 0 4 _aThiocarbamates
650 0 4 _aThiones
_xtherapeutic use
650 0 4 _aType C Phospholipases
_xantagonists & inhibitors
650 0 4 _aUvea
_xpathology
650 0 4 _aUveitis
_xchemically induced
700 1 _aShen, D F
700 1 _aChan, C C
773 0 _tJournal of autoimmunity
_gvol. 13
_gno. 2
_gp. 197-204
856 4 0 _uhttps://doi.org/10.1006/jaut.1999.0319
_zAvailable from publisher's website
999 _c10436793
_d10436793